While the specific details of the company's last investment round and its investors are not available at present, Rare Cannabinoid Company's unique product range and commitment to quality manufacturing and testing could position it favorably in the rapidly growing cannabinoid market. As the use of cannabinoids for wellness and medical purposes continues to gain traction, the company's emphasis on rare and full spectrum offerings could prove to be a point of differentiation, potentially attracting interest from venture capital firms seeking exposure to this burgeoning sector.
General Information
BounceWatch is an independent company data service, not affiliated with Rare Cannabinoid Company. To contact Rare Cannabinoid Company, visit rarecannabinoidco.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Health Care
About Rare Cannabinoid Company
Taxonomy: CBD, THC, cannabinoids, health, hemp, supplements, tinctures, cannabis, CBN, CBG, CBC, THCV, terpenes, lab-tested
No funding data available for Rare Cannabinoid Company yet.
Rare Cannabinoid Company Alternatives & Competitors
Offering pain relief for those suffering from chronic pain conditions.
Planta Scientific is a Miami-based innovation laboratory specializing in nano-cannabinoids and CPG f...
AMMA brings healing, balance, and wellness to our planet, by providing the highest-quality, 100% org...
FAQ About Rare Cannabinoid Company
Source: BounceWatch company record for Rare Cannabinoid Company, https://bouncewatch.com/company/rare-cannabinoid-company, updated 2 January 2025. When citing, please name BounceWatch and link this page.